Financials

  • Market Capitalization 2.46 B
  • Employee 361
  • Founded 2016
  • CEO N/A
  • Website www.veratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00Q72WYG3
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-7.32
市销率
-2 874.39

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
1856
PGEN
Precigen, Inc. - Common Stock
6.93 USD-0.29%-4.94%+11.24%+54.34%2.48 B USD
1857
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
9.70 USD-1.22%-0.92%+7.78%+15.89%2.48 B USD
1868
NKTR
Nektar Therapeutics - Common Stock
71.38 USD-1.57%-4.80%+0.93%-2.58%2.44 B USD
1887
TRVI
Trevi Therapeutics, Inc. - Common Stock
16.60 USD-1.13%-9.24%-9.44%+132.17%2.37 B USD

新闻